Company intelligence / Profile preview
Betta Pharmaceuticals
Hangzhou, Zhejiang, Chinabettapharma.com ↗
- Ownership
- Public · 300558
- Development stage
- Other
01
Overview
Betta Pharmaceuticals has successfully developed and commercialized several innovative oncology drugs including Icotinib hydrochloride for NSCLC and Ensartinib hydrochloride for ALK-positive NSCLC. The company also markets a bevacizumab biosimilar. Its pipeline features small molecules and biologics targeting key oncogenic pathways such as EGFR/ALK/c-Met/PD-L1/HIF/TEAD. Several programs are in clinical development for various solid tumors and hematological malignancies
- Therapeutic areas
- OphthalmologyOncology
- Modalities
- Small moleculesmonoclonal antibodies (mAbs)bispecific antibodiesbiosimilars
- Industry
- Biotech
02
Drug pipeline
29 assets28 more assets in the full pipeline.
03
Partnerships
Sinopharm Group Co., Ltd.Heyuan BiopharmaHangzhou Ruipu ChenchuangEyePoint Pharmaceuticals for EYP‑1901 program
04
Financials
- Market cap
- $3B
- Total revenue
- $541.1M
- Enterprise value
- $3.3B
Beyond the preview
Go deeper on Betta Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Betta Pharmaceuticals.